# Immunovant, Inc.: Form 4, filed Sep 18, 2020

- Company: [Immunovant, Inc.](/companies/imvt.md) (CIK 1764013)
- Form: 4
- Filed: 2020-09-18
- Accepted by EDGAR: Sep 18, 2020, 16:33 ET
- Period: 2020-09-17
- Accession: 0001104659-20-106546
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1764013/000110465920106546/xslF345X03/a4.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1764013/000110465920106546/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1764013/000110465920106546/xslF345X03/a4.xml

Filed Sep 18, 2020.
Source: SEC EDGAR, the filing index for accession 0001104659-20-106546. Last ingested by Listed: Oct 30, 2026, 16:48 ET. No prices; not investment advice.